Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Abstract: Disclosed herein are extruded articles such as, for example, fibers and films, containing thermoplastic polymeric compositions having a copolymeric major component and a melt processable additive treatment, wherein the melt processable additives have enhanced segregation to or expression at the surface of the article, thereby improving the effect of the desired characteristic of the additive treatment. Also disclosed are multicomponent extruded thermoplastic articles having two or more distinct components arranged in a specific geometric arrangement, wherein the thermoplastic polymeric composition of at least one geometric component includes a copolymeric major component and a melt processable additive treatment. Also disclosed are web materials including the extruded articles.

Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

Abstract: In a shared storage infrastructure accessible by more than one customer, the shared storage infrastructure is separated into a plurality of logical storage areas. A customer is associated with at least one logical storage area within the shared storage infrastructure. The customer and its logical storage areas are associated with at least one port in the shared storage infrastructure. Each customer has access only to the logical storage areas associated with the customer and cannot access the logical storage areas of any other customer. The shared storage infrastructure provides policy based storage management to each customer, that is, each customer appears to have access to a non-shared storage subsystem. By providing a virtualization layer, a customer may be given the ability to manage its own storage needs.

Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Abstract: A thermal manager has a digital filter whose input is to receive raw temperature values from a sensor and whose output is to provide processed or filtered temperature values according to a filter function that correlates temperature at the sensor with temperature at another location in the device. The thermal manager has a look-up table that further correlates temperature at the sensor with temperature at said another location. The look-up table contains a list of processed temperature sensor values, and/or a list of temperatures representing the temperature at said another location, and their respective power consumption change commands. The thermal manager accesses the look-up table using selected, filtered temperature values, to identify their respective power consumption change commands. The latter are then evaluated and may be applied, to mitigate a thermal at said another location. Other embodiments are also described and claimed.

Abstract: Methods of treating humans or animals having various conditions are disclosed which include administering a therapeutically effective amount of a cyclosporine component to the human or animal, thereby treating the condition. Among the conditions treated are systemic lupus eryhematosis, multiple sclerosis, maloplabia of the skin, oral frictional hyperkeratosis, oral manifestations of autoimmune blistering disease, oral lichen planus, aphthous ulcers, nasal polyps, rhinosporiodosis, sinusitis, iritis, carcinoid lung, laryngitis and atrophic gastritis.

Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

Abstract: Disclosed herein are extruded articles such as, for example, fibers and films, containing thermoplastic polymeric compositions having a copolymeric major component and a melt processable additive treatment, wherein the melt processable additives have enhanced segregation to or expression at the surface of the article, thereby improving the effect of the desired characteristic of the additive treatment. Also disclosed are multicomponent extruded thermoplastic articles having two or more distinct components arranged in a specific geometric arrangement, wherein the thermoplastic polymeric composition of at least one geometric component includes a copolymeric major component and a melt processable additive treatment. Also disclosed are web materials including the extruded articles.

Abstract: A nonwoven acoustic insulating material which also provides repellency to water and low surface tension fluids. Also disclosed is a method for attenuating transmitted sound and repelling fluids which includes providing a nonwoven acoustic insulating material, the nonwoven acoustic insulating material including at least one nonwoven web having a low surface tension fluids repellency treatment, and interposing the treated nonwoven acoustic insulating material between a sound generation area and a sound receiving area.

Abstract: The present invention provides chimeric and humanized antibodies that specifically recognize ?5?1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

Abstract: The invention relates to a sensor for indicating the transduction and inhibition of stress signals through the p38-MAPK pathway in living cells. The sensor comprises a reporter gene product and an isoform of p38 Mitogen Activated Protein Kinase (MAPK). The invention also provides plasmid and viral vectors containing nucleic acids encoding the sensor for the transfection of living cells. Stable cell lines expressing the sensor can be used in a live-cell or fixed-cell assay to measure activation or modulation of the pathway.

Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Abstract: Methods of treating humans or animals having rheumatoid arthritis are disclosed which include topically administering a therapeutically effective amount of a cyclosporine component to the human or animal, thereby treating the rheumatoid arthritis.

Abstract: Methods of treating humans or animals having various conditions are disclosed which include administering a therapeutically effective amount of a cyclosporine component to the human or animal, thereby treating the condition. Among the conditions treated are systemic lupus erythematosis, multiple sclerosis, maloplabia of the skin, oral frictional hyperkeratosis, oral manifestations of autoimmune blistering disease, oral lichen planus, aphthous ulcers, nasal polyps, rhinosporiodosis, sinusitis, iritis, carcinoid lung, laryngitis and atrophic gastritis.